신생아 호흡곤란증후군의 폐 표면활성제 치료

키워드

참고문헌 (44)

1. Abdel-Latif ME, "Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome", Cochrane Database Syst Rev, 1, pp.CD008309~ (2024)
2. Avery ME, "Surface properties in relation to atelectasis and hyaline membrane disease", AMA J Dis Child, 97(5, Part 1), pp.517~523 (1959)
3. Bae CW, "History of pulmonary surfactant replacement therapy for neonatal respiratory distress syndrome in Korea", J Korean Med Sci, 34, pp.e175~ (2019)
4. Bahadue FL, "Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome", Cochrane Database Syst Rev, 11, pp.CD001456~ (2012)
5. Choi HJ, "Surfactant lavage therapy for meconium aspiration syndrome : a systematic review and meta-analysis", Neonatology, 101, pp.183~191 (2012)
6. Committee on Fetus, "Respiratory support in preterm infants at birth", Pediatrics, 133, pp.171~174 (2014)
7. Dani C, "Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants <30 weeks’ gestation", Pediatrics, 113, pp.e560~e563 (2004)
8. Dargaville PA, "Preliminary evaluation of a new technique of minimally invasive surfactant therapy", Arch Dis Child Fetal Neonatal Ed, 96, pp.F243~F248 (2011)
9. Dargaville PA, "Continuous positive airway pressure failure in preterm infants : incidence, predictors and consequences", Neonatology, 104, pp.8~14 (2013)
10. El Shahed AI, "Surfactant for meconium aspiration syndrome in full term", near term infants, 2007, pp.3, CD002054~
11. European Exosurf Study Group, "Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis", Online J Curr Clin Trials (1992)
12. Finer NN, "Early CPAP versus surfactant in extremely preterm infants", N Engl J Med, 362, pp.1970~1979 (2010)
13. Fuchs H, "Predictors of early nasal CPAP failure and effects of various intubation criteria on the rate of mechanical ventilation in preterm infants of <29 weeks gestational age", Arch Dis Child Fetal Neonatal Ed, 96, pp.F343~F347 (2011)
14. Fujiwara T, "Artificial surfactant therapy in hyaline-membrane disease", Lancet, 1, pp.55~59 (1980)
15. Gruenwald P, "Surface tension as a factor in the resistance of neonatal lungs to aeration", Am J Obstet Gynecol, 53, pp.996~1007 (1947)
16. Hallman M, "Historical perspective on surfactant therapy : transforming hyaline membrane disease to respiratory distress syndrome", Semin Fetal Neonatal Med, 28, pp.101493~ (2023)
17. Hillman N, "Noninvasive strategies for management of respiratory problems in neonates", Neoreviews, 14, pp.e227~e236 (2013)
18. Hong CY, "Pediatrics" (2020), Mirae N
19. Isayama T, "Association of noninvasive ventilation strategies with mortality and bronchopulmonary dysplasia among preterm infants : a systematic review and metaanalysis", JAMA, 316, pp.611~624 (2016)
20. Jeon GW, "Surfactant preparations for preterm infants with respiratory distress syndrome : past, present, and future", Korean J Pediatr, 62, pp.155~161 (2019)
21. Jeon GW, "Serial short-term outcomes of very-low-birth-weight infants in the Korean Neonatal Network from 2013 to 2020", J Korean Med Sci, 37, pp.e229~ (2022)
22. Kanmaz HG, "Surfactant administration via thin catheter during spontaneous breathing : randomized controlled trial", Pediatrics, 131, pp.e502~e509 (2013)
23. Kesler H, "Thincatheter surfactant application for respiratory distress syndrome in spontaneously breathing preterm infants : a meta-analysis of randomized clinical trials", Curr Pediatr Rev, 18, pp.286~300 (2022)
24. Klebermass-Schrehof K, "Less invasive surfactant administration in extremely preterm infants : impact on mortality and morbidity", Neonatology, 103, pp.252~258 (2013)
25. Kolatat T, "Airway complications in neonates who received mechanical ventilation", J Med Assoc Thai, 85(Suppl 2), pp.S455~S462 (2002)
26. Kribs A, "Early administration of surfactant in spontaneous breathing with nCPAP : feasibility and outcome in extremely premature infants(postmenstrual age <", =27 weeks), 2007, pp.17, 364~369
27. Ma CC, "The role of surfactant in respiratory distress syndrome", Open Respir Med J, 6, pp.44~53 (2012)
28. Morley CJ, "Nasal CPAP or intubation at birth for very preterm infants", N Engl J Med, 358, pp.700~708 (2008)
29. Ng EH, "Guidelines for surfactant replacement therapy in neonates", Paediatr Child Health, 26, pp.35~49 (2021)
30. Plavka R, "Early versus delayed surfactant administration in extremely premature neonates with respiratory distress syndrome ventilated by high-frequency oscillatory ventilation", Intensive Care Med, 28, pp.1483~1490 (2002)
31. Polin RA, "Surfactant replacement therapy for preterm and term neonates with respiratory distress", Pediatrics, 133, pp.156~163 (2014)
32. Ramaswamy VV, "Efficacy of noninvasive respiratory support modes for primary respiratory support in preterm neonates with respiratory distress syndrome : Systematic review and network meta-analysis", Pediatr Pulmonol, 55, pp.2940~2963 (2020)
33. Rojas MA, "Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure : a randomized, controlled trial", Pediatrics, 123, pp.137~142 (2009)
34. Rojas-Reyes MX, "Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants", Cochrane Database Syst Rev, 3, pp.CD000510~ (2012)
35. Shim GH, "Update of minimally invasive surfactant therapy", Korean J Pediatr, 60, pp.273~281 (2017)
36. Shin JE, "Pulmonary surfactant replacement therapy for respiratory distress syndrome in neonates : a nationwide epidemiological study in Korea", J Korean Med Sci, 35, pp.e253~ (2020)
37. Silveira RC, "Less invasive surfactant administration versus intubation-surfactant-extubation in the treatment of neonatal respiratory distress syndrome : a systematic review and meta-analyses", J Pediatr(Rio J), 100, pp.8~24 (2024)
38. Soll RF, "Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants", Cochrane Database Syst Rev, 2, pp.CD000510~ (2001)
39. Stevens TP, "Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome", Cochrane Database Syst Rev, 2007, pp.CD003063~ (2007)
40. Sweet DG, "European Consensus Guidelines on the management of respiratory distress syndrome : 2022 update", Neonatology, 120, pp.3~23 (2023)
41. Sweet DG, "European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants-2013 update", Neonatology, 103, pp.353~368 (2013)
42. Sweet DG, "European Consensus Guidelines on the management of respiratory distress syndrome-2019 update", Neonatology, 115, pp.432~450 (2019)
43. Venkatesh V, "Endotracheal intubation in a neonatal population remains associated with a high risk of adverse events", Eur J Pediatr, 170, pp.223~227 (2011)
44. Verder H, "Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks’ gestation", Pediatrics, 103, pp.E24~ (1999)

관련 논문AI추천